Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines - PubMed (original) (raw)
. 1995 Feb 1;85(3):790-8.
Affiliations
- PMID: 7530509
Free article
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines
H Kitayama et al. Blood. 1995.
Free article
Abstract
The c-kit receptor tyrosine kinase (KIT) is activated upon ligand binding, thereby leading to a variety of signaling events that play a fundamental role in hematopoiesis. In addition to ligand-dependent activation, we have previously shown that KIT is constitutively activated in a ligand-independent manner by two point mutations, Val-559-->Gly (G559) mutation in the juxtamembrane domain and Asp-814-->Val (V814) mutation in the phosphotransferase domain. To investigate the biochemical consequence and biologic significance of these mutations, retroviral vectors encoding KITG559 or KITV814 were introduced into murine pro-B-type Ba/F3 cells and myeloid FDC-P1 cells, both of which require interleukin-3 (IL-3) for their growth and survival. In the cells, KITG559 or KITV814 were found to be constitutively phophorylated on tyrosine in the absence of stem cell factor (SCF) that is a ligand for KIT. Chemical cross-linking analysis showed that a substantial fraction of the phosphorylated KITG559 underwent dimerization even in the absence of SCF, whereas the phosphorylated KITV814 did not, suggesting the distinct mechanisms underlying constitutive activation of KIT by G559 and V814 mutations. Furthermore, the cells expressing either KITG559 or KITV814 were found to show a factor-independent growth, whereas the cells expressing wild-type KIT (KITWT) proliferated in response to SCF as well as IL-3. Moreover, subcutaneous injection of Ba/F3 cells expressing KITG559 or KITV814 into nude mice resulted in production of large tumors at all sites of the injection within 2 weeks, and all nude mice quickly succumbed to leukemia and died. These results suggest that, although the mechanisms underlying constitutive activation of KITG559 or KITV814 may be different, both of the activating mutations have a function to induce a factor-independent and tumorigenic phenotype. Also, the data of this study raise the possibility that the constitutively activating mutations of c-kit may play a causal role in development of hematologic malignancies.
Similar articles
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, et al. Furitsu T, et al. J Clin Invest. 1993 Oct;92(4):1736-44. doi: 10.1172/JCI116761. J Clin Invest. 1993. PMID: 7691885 Free PMC article. - Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin-3-dependent mast cell line.
Hashimoto K, Tsujimura T, Moriyama Y, Yamatodani A, Kimura M, Tohya K, Morimoto M, Kitayama H, Kanakura Y, Kitamura Y. Hashimoto K, et al. Am J Pathol. 1996 Jan;148(1):189-200. Am J Pathol. 1996. PMID: 8546206 Free PMC article. - Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase.
Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J, Okabe M, Suzuki M, Yamamura K, Matsuzawa Y, Kitamura Y, Kanakura Y. Kitayama H, et al. Blood. 1996 Aug 1;88(3):995-1004. Blood. 1996. PMID: 8704259 - Structure-function analyses of the kit receptor for the steel factor.
Blechman JM, Lev S, Givol D, Yarden Y. Blechman JM, et al. Stem Cells. 1993 Jul;11 Suppl 2:12-21. doi: 10.1002/stem.5530110804. Stem Cells. 1993. PMID: 7691317 Review. - Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG. Drexler HG. Leukemia. 1996 Apr;10(4):588-99. Leukemia. 1996. PMID: 8618433 Review.
Cited by
- Immortalized erythroid cells as a novel frontier for in vitro blood production: current approaches and potential clinical application.
Cervellera CF, Mazziotta C, Di Mauro G, Iaquinta MR, Mazzoni E, Torreggiani E, Tognon M, Martini F, Rotondo JC. Cervellera CF, et al. Stem Cell Res Ther. 2023 May 24;14(1):139. doi: 10.1186/s13287-023-03367-8. Stem Cell Res Ther. 2023. PMID: 37226267 Free PMC article. Review. - CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis.
Bandara G, Falduto GH, Luker A, Bai Y, Pfeiffer A, Lack J, Metcalfe DD, Olivera A. Bandara G, et al. Front Immunol. 2023 Mar 21;14:1078958. doi: 10.3389/fimmu.2023.1078958. eCollection 2023. Front Immunol. 2023. PMID: 37025992 Free PMC article. - Recent Advances in the Molecular Biology of Systemic Mastocytosis: Implications for Diagnosis, Prognosis, and Therapy.
Martelli M, Monaldi C, De Santis S, Bruno S, Mancini M, Cavo M, Soverini S. Martelli M, et al. Int J Mol Sci. 2020 Jun 2;21(11):3987. doi: 10.3390/ijms21113987. Int J Mol Sci. 2020. PMID: 32498255 Free PMC article. Review. - Bioisosteric Discovery of NPA101.3, a Second-Generation RET/VEGFR2 Inhibitor Optimized for Single-Agent Polypharmacology.
Moccia M, Frett B, Zhang L, Lakkaniga NR, Briggs DC, Chauhan R, Brescia A, Federico G, Yan W, Santoro M, McDonald NQ, Li HY, Carlomagno F. Moccia M, et al. J Med Chem. 2020 May 14;63(9):4506-4516. doi: 10.1021/acs.jmedchem.9b01336. Epub 2020 Apr 28. J Med Chem. 2020. PMID: 32298114 Free PMC article. - Relationship between diagnostic imaging features and prognostic outcomes in gastrointestinal stromal tumors (GIST).
Danti G, Addeo G, Cozzi D, Maggialetti N, Lanzetta MM, Frezzetti G, Masserelli A, Pradella S, Giovagnoni A, Miele V. Danti G, et al. Acta Biomed. 2019 Apr 24;90(5-S):9-19. doi: 10.23750/abm.v90i5-S.8343. Acta Biomed. 2019. PMID: 31085970 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous